DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Vaccines Against Salmonella Typhi

Phase 2

Completed

Conditions: Typhoid Fever
Enteric Fever

Interventions: Biological: Vi-TCV
Biological: Control (Men ACWY)
Biological: Vi-PS Vaccine

First Posted Date: 2014-12-24

Last Posted Date: 2022-07-05

Lead Sponsor: University of Oxford

Target Recruit Count: 112

Registration Number: NCT02324751

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Pharmacokinetic and Pharmacodynamic Study of Mefloquine and Dihydroartemisinin-Piperaquine in Healthy Subjects

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: Mefloquine and Dihydroartemisinin-piperaquine
Other: Wash-out period
Drug: Mefloquine

First Posted Date: 2014-12-24

Last Posted Date: 2015-11-03

Lead Sponsor: University of Oxford

Target Recruit Count: 16

Registration Number: NCT02324738

Locations: 🇹🇭
Faculty of Tropical Medicine, Bangkok, Thailand

Yoga in Adult Cancer: A Feasibility Trial

Not Applicable

Completed

Conditions: Quality of Life

Interventions: Other: Yoga

First Posted Date: 2014-12-05

Last Posted Date: 2015-02-10

Lead Sponsor: University of Oxford

Target Recruit Count: 15

Registration Number: NCT02309112

Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis

Phase 3

Completed

Conditions: Encephalitis

Interventions: Drug: Immunoglobulins, Intravenous (Privigen)
Drug: Placebo

First Posted Date: 2014-12-05

Last Posted Date: 2024-03-04

Lead Sponsor: University of Oxford

Target Recruit Count: 18

Registration Number: NCT02308982

Locations: 🇬🇧
Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
🇬🇧
Grampian Health Board, Aberdeen, United Kingdom
🇬🇧
Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom

and more 22 locations

SBRT Pre-operatively for Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Neoplasms

Interventions: Radiation: 5-fraction stereotactic body radiation therapy

First Posted Date: 2014-12-04

Last Posted Date: 2021-10-07

Lead Sponsor: University of Oxford

Target Recruit Count: 12

Registration Number: NCT02308722

Locations: 🇬🇧
The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
🇬🇧
St James' Hospital, Leeds, United Kingdom
🇬🇧
City Hospital, Nottingham, United Kingdom

and more 2 locations

Iron Status and Human Metabolism

Not Applicable

Completed

Conditions: Iron Deficiency

Interventions: Drug: Sodium chloride (placebo)
Drug: Ferric carboxymaltose

First Posted Date: 2014-12-04

Last Posted Date: 2022-07-19

Lead Sponsor: University of Oxford

Target Recruit Count: 29

Registration Number: NCT02308449

Locations: 🇬🇧
University of Oxford OCMR & CCRF, John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom

PATH-2: Platelet Rich Plasma in Achilles Tendon Healing

Not Applicable

Completed

Conditions: Achilles Tendon Rupture

Interventions: Procedure: PRP Injection into Achilles tendon rupture gap
Procedure: Imitation Injection into Achilles tendon rupture gap

First Posted Date: 2014-11-27

Last Posted Date: 2021-05-05

Lead Sponsor: University of Oxford

Target Recruit Count: 230

Registration Number: NCT02302664

Locations: 🇬🇧
Basildon University Hospital, Basildon, United Kingdom
🇬🇧
University Hospital Coventry, Coventry, United Kingdom
🇬🇧
Leicester Royal Infirmary, Leicester, United Kingdom

and more 15 locations

A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Phase 1

Conditions: Ebola Virus Disease

Interventions: Biological: VSV-ZEBOV

First Posted Date: 2014-11-21

Last Posted Date: 2016-04-14

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT02296983

Locations: 🇰🇪
KEMRI Wellcome Trust Research Programme, Kilifi, Coast, Kenya

Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering

Not Applicable

Completed

Conditions: Speech Disorders
Stuttering
Fluency Disorders

Interventions: Behavioral: Fluency Training
Device: Anodal TDCS

First Posted Date: 2014-11-11

Last Posted Date: 2017-01-31

Lead Sponsor: University of Oxford

Target Recruit Count: 30

Registration Number: NCT02288598

Locations: 🇬🇧
University of Oxford, Oxford, United Kingdom

A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S

Phase 1

Completed

Conditions: Plasmodium Falciparum Malaria

Interventions: Biological: RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01)
Biological: ChAd63 ME-TRAP (5 x 10^10 vp)
Biological: RTS,S/AS01B (10mcg of RTS,S and one fifth of the standard dose of AS01)
Biological: MVA ME-TRAP (2 x 10^8 pfu)

First Posted Date: 2014-09-30

Last Posted Date: 2015-12-03

Lead Sponsor: University of Oxford

Target Recruit Count: 48

Registration Number: NCT02252640

Locations: 🇬🇧
NIHR WTCRF, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom
🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom
🇬🇧
NIHR/Wellcome Trust Imperial CRF, Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy